Loading…
Residential Magnetic Fields, Light-at-Night, and Nocturnal Urinary 6-Sulfatoxymelatonin Concentration in Women
Exposure to 60-Hz magnetic fields may increase breast cancer risk by suppressing the normal nocturnal rise in melatonin. This 1994–1996 Washington State study investigated whether such exposure was associated with lower nocturnal urinary concentration of 6-sulfatoxymelatonin in 203 women aged 20–74...
Saved in:
Published in: | American journal of epidemiology 2001-10, Vol.154 (7), p.591-600 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c450t-a3a1a519613527040d329a793e88f2c0f9b9a38de8c6bc4566ba80ed891c6a483 |
---|---|
cites | |
container_end_page | 600 |
container_issue | 7 |
container_start_page | 591 |
container_title | American journal of epidemiology |
container_volume | 154 |
creator | Davis, Scott Kaune, William T. Mirick, Dana K. Chen, Chu Stevens, Richard G. |
description | Exposure to 60-Hz magnetic fields may increase breast cancer risk by suppressing the normal nocturnal rise in melatonin. This 1994–1996 Washington State study investigated whether such exposure was associated with lower nocturnal urinary concentration of 6-sulfatoxymelatonin in 203 women aged 20–74 years with no history of breast cancer. Each woman was interviewed and provided data on the following for a 72-hour period at two different seasons of the year: 1) magnetic field and ambient light measured every 30 seconds in her bedroom, 2) personal magnetic field measured at 30-second intervals, and 3) complete nighttime urine samples on three consecutive nights. Lower nocturnal urinary 6-sulfatoxymelatonin level was associated with more hours of daylight, older age, higher body mass index, current alcohol consumption, and current use of medications classified as beta blockers, calcium channel blockers, or psychotropics. After adjustment for these factors, higher bedroom magnetic field level was associated with significantly lower urinary concentration of 6-sulfatoxymelatonin during the same night, primarily in women who used these medications and during times of the year with the fewest hours of darkness. These results suggest that exposure to nighttime residential 60-Hz magnetic fields can depress the normal nocturnal rise in melatonin. |
doi_str_mv | 10.1093/aje/154.7.591 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71209341</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71209341</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-a3a1a519613527040d329a793e88f2c0f9b9a38de8c6bc4566ba80ed891c6a483</originalsourceid><addsrcrecordid>eNpdkd9PFDEQxxsjkQN99NVsTOSJPfpj--sRL55ITkhAouGlmet2seduF9tuAv-9RS5e4tNMpp_5Tme-CL0leE6wZiewcSeEN3M555q8QDPSSFELysVLNMMY01pTQffRQUobjAnRHL9C-4RwVbrpDIUrl3zrQvbQV1_hLrjsbbX0rm_TcbXydz9zDbm-eEqOKwhtdTHaPMVQ8JvoA8THStTXU99BHh8eB9eXGHyoFmOwRTZC9mOoSuH7OLjwGu110Cf3ZhsP0c3y07fFWb26_PxlcbqqbcNxmciAACdaEMapxA1uGdUgNXNKddTiTq81MNU6ZcW6tAixBoVdqzSxAhrFDtHRs-59HH9PLmUz-GRd30Nw45SMJLQcryEFfP8fuBn_bpcMZVwJ1XBZoPoZsnFMKbrO3Ec_lNUNwebJBVNcMMUFI01xofDvtqLTenDtjt6evQAftgAkC30XIVifdlz5WKNlsxvsU3YP_94h_jJCMsnN2Y9bI5a3y4_nV9Jg9gfqqJ6Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>235868457</pqid></control><display><type>article</type><title>Residential Magnetic Fields, Light-at-Night, and Nocturnal Urinary 6-Sulfatoxymelatonin Concentration in Women</title><source>Oxford Journals Online</source><creator>Davis, Scott ; Kaune, William T. ; Mirick, Dana K. ; Chen, Chu ; Stevens, Richard G.</creator><creatorcontrib>Davis, Scott ; Kaune, William T. ; Mirick, Dana K. ; Chen, Chu ; Stevens, Richard G.</creatorcontrib><description>Exposure to 60-Hz magnetic fields may increase breast cancer risk by suppressing the normal nocturnal rise in melatonin. This 1994–1996 Washington State study investigated whether such exposure was associated with lower nocturnal urinary concentration of 6-sulfatoxymelatonin in 203 women aged 20–74 years with no history of breast cancer. Each woman was interviewed and provided data on the following for a 72-hour period at two different seasons of the year: 1) magnetic field and ambient light measured every 30 seconds in her bedroom, 2) personal magnetic field measured at 30-second intervals, and 3) complete nighttime urine samples on three consecutive nights. Lower nocturnal urinary 6-sulfatoxymelatonin level was associated with more hours of daylight, older age, higher body mass index, current alcohol consumption, and current use of medications classified as beta blockers, calcium channel blockers, or psychotropics. After adjustment for these factors, higher bedroom magnetic field level was associated with significantly lower urinary concentration of 6-sulfatoxymelatonin during the same night, primarily in women who used these medications and during times of the year with the fewest hours of darkness. These results suggest that exposure to nighttime residential 60-Hz magnetic fields can depress the normal nocturnal rise in melatonin.</description><identifier>ISSN: 0002-9262</identifier><identifier>EISSN: 1476-6256</identifier><identifier>EISSN: 0002-9262</identifier><identifier>DOI: 10.1093/aje/154.7.591</identifier><identifier>PMID: 11581092</identifier><identifier>CODEN: AJEPAS</identifier><language>eng</language><publisher>Cary, NC: Oxford University Press</publisher><subject>Adrenergic beta-Antagonists - pharmacology ; Adult ; Age Factors ; Aged ; Alcohol Drinking ; Biological and medical sciences ; BMI ; Body Mass Index ; breast neoplasms ; Breast Neoplasms - etiology ; Calcium Channel Blockers - pharmacology ; carcinogens ; Circadian Rhythm ; electricity ; electromagnetic fields ; environmental ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; Lighting ; Magnetics ; Mammary gland diseases ; Medical sciences ; melatonin ; Melatonin - analogs & derivatives ; Melatonin - urine ; Menopause ; Middle Aged ; Psychotropic Drugs - pharmacology ; Residence Characteristics ; Risk Factors ; Seasons ; Smoking ; Tumors</subject><ispartof>American journal of epidemiology, 2001-10, Vol.154 (7), p.591-600</ispartof><rights>2002 INIST-CNRS</rights><rights>Copyright Oxford University Press(England) Oct 01, 2001</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-a3a1a519613527040d329a793e88f2c0f9b9a38de8c6bc4566ba80ed891c6a483</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14134974$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11581092$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Davis, Scott</creatorcontrib><creatorcontrib>Kaune, William T.</creatorcontrib><creatorcontrib>Mirick, Dana K.</creatorcontrib><creatorcontrib>Chen, Chu</creatorcontrib><creatorcontrib>Stevens, Richard G.</creatorcontrib><title>Residential Magnetic Fields, Light-at-Night, and Nocturnal Urinary 6-Sulfatoxymelatonin Concentration in Women</title><title>American journal of epidemiology</title><addtitle>Am. J. Epidemiol</addtitle><description>Exposure to 60-Hz magnetic fields may increase breast cancer risk by suppressing the normal nocturnal rise in melatonin. This 1994–1996 Washington State study investigated whether such exposure was associated with lower nocturnal urinary concentration of 6-sulfatoxymelatonin in 203 women aged 20–74 years with no history of breast cancer. Each woman was interviewed and provided data on the following for a 72-hour period at two different seasons of the year: 1) magnetic field and ambient light measured every 30 seconds in her bedroom, 2) personal magnetic field measured at 30-second intervals, and 3) complete nighttime urine samples on three consecutive nights. Lower nocturnal urinary 6-sulfatoxymelatonin level was associated with more hours of daylight, older age, higher body mass index, current alcohol consumption, and current use of medications classified as beta blockers, calcium channel blockers, or psychotropics. After adjustment for these factors, higher bedroom magnetic field level was associated with significantly lower urinary concentration of 6-sulfatoxymelatonin during the same night, primarily in women who used these medications and during times of the year with the fewest hours of darkness. These results suggest that exposure to nighttime residential 60-Hz magnetic fields can depress the normal nocturnal rise in melatonin.</description><subject>Adrenergic beta-Antagonists - pharmacology</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Alcohol Drinking</subject><subject>Biological and medical sciences</subject><subject>BMI</subject><subject>Body Mass Index</subject><subject>breast neoplasms</subject><subject>Breast Neoplasms - etiology</subject><subject>Calcium Channel Blockers - pharmacology</subject><subject>carcinogens</subject><subject>Circadian Rhythm</subject><subject>electricity</subject><subject>electromagnetic fields</subject><subject>environmental</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Lighting</subject><subject>Magnetics</subject><subject>Mammary gland diseases</subject><subject>Medical sciences</subject><subject>melatonin</subject><subject>Melatonin - analogs & derivatives</subject><subject>Melatonin - urine</subject><subject>Menopause</subject><subject>Middle Aged</subject><subject>Psychotropic Drugs - pharmacology</subject><subject>Residence Characteristics</subject><subject>Risk Factors</subject><subject>Seasons</subject><subject>Smoking</subject><subject>Tumors</subject><issn>0002-9262</issn><issn>1476-6256</issn><issn>0002-9262</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNpdkd9PFDEQxxsjkQN99NVsTOSJPfpj--sRL55ITkhAouGlmet2seduF9tuAv-9RS5e4tNMpp_5Tme-CL0leE6wZiewcSeEN3M555q8QDPSSFELysVLNMMY01pTQffRQUobjAnRHL9C-4RwVbrpDIUrl3zrQvbQV1_hLrjsbbX0rm_TcbXydz9zDbm-eEqOKwhtdTHaPMVQ8JvoA8THStTXU99BHh8eB9eXGHyoFmOwRTZC9mOoSuH7OLjwGu110Cf3ZhsP0c3y07fFWb26_PxlcbqqbcNxmciAACdaEMapxA1uGdUgNXNKddTiTq81MNU6ZcW6tAixBoVdqzSxAhrFDtHRs-59HH9PLmUz-GRd30Nw45SMJLQcryEFfP8fuBn_bpcMZVwJ1XBZoPoZsnFMKbrO3Ec_lNUNwebJBVNcMMUFI01xofDvtqLTenDtjt6evQAftgAkC30XIVifdlz5WKNlsxvsU3YP_94h_jJCMsnN2Y9bI5a3y4_nV9Jg9gfqqJ6Y</recordid><startdate>20011001</startdate><enddate>20011001</enddate><creator>Davis, Scott</creator><creator>Kaune, William T.</creator><creator>Mirick, Dana K.</creator><creator>Chen, Chu</creator><creator>Stevens, Richard G.</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T2</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20011001</creationdate><title>Residential Magnetic Fields, Light-at-Night, and Nocturnal Urinary 6-Sulfatoxymelatonin Concentration in Women</title><author>Davis, Scott ; Kaune, William T. ; Mirick, Dana K. ; Chen, Chu ; Stevens, Richard G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-a3a1a519613527040d329a793e88f2c0f9b9a38de8c6bc4566ba80ed891c6a483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adrenergic beta-Antagonists - pharmacology</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Alcohol Drinking</topic><topic>Biological and medical sciences</topic><topic>BMI</topic><topic>Body Mass Index</topic><topic>breast neoplasms</topic><topic>Breast Neoplasms - etiology</topic><topic>Calcium Channel Blockers - pharmacology</topic><topic>carcinogens</topic><topic>Circadian Rhythm</topic><topic>electricity</topic><topic>electromagnetic fields</topic><topic>environmental</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Lighting</topic><topic>Magnetics</topic><topic>Mammary gland diseases</topic><topic>Medical sciences</topic><topic>melatonin</topic><topic>Melatonin - analogs & derivatives</topic><topic>Melatonin - urine</topic><topic>Menopause</topic><topic>Middle Aged</topic><topic>Psychotropic Drugs - pharmacology</topic><topic>Residence Characteristics</topic><topic>Risk Factors</topic><topic>Seasons</topic><topic>Smoking</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Davis, Scott</creatorcontrib><creatorcontrib>Kaune, William T.</creatorcontrib><creatorcontrib>Mirick, Dana K.</creatorcontrib><creatorcontrib>Chen, Chu</creatorcontrib><creatorcontrib>Stevens, Richard G.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of epidemiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Davis, Scott</au><au>Kaune, William T.</au><au>Mirick, Dana K.</au><au>Chen, Chu</au><au>Stevens, Richard G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Residential Magnetic Fields, Light-at-Night, and Nocturnal Urinary 6-Sulfatoxymelatonin Concentration in Women</atitle><jtitle>American journal of epidemiology</jtitle><addtitle>Am. J. Epidemiol</addtitle><date>2001-10-01</date><risdate>2001</risdate><volume>154</volume><issue>7</issue><spage>591</spage><epage>600</epage><pages>591-600</pages><issn>0002-9262</issn><eissn>1476-6256</eissn><eissn>0002-9262</eissn><coden>AJEPAS</coden><abstract>Exposure to 60-Hz magnetic fields may increase breast cancer risk by suppressing the normal nocturnal rise in melatonin. This 1994–1996 Washington State study investigated whether such exposure was associated with lower nocturnal urinary concentration of 6-sulfatoxymelatonin in 203 women aged 20–74 years with no history of breast cancer. Each woman was interviewed and provided data on the following for a 72-hour period at two different seasons of the year: 1) magnetic field and ambient light measured every 30 seconds in her bedroom, 2) personal magnetic field measured at 30-second intervals, and 3) complete nighttime urine samples on three consecutive nights. Lower nocturnal urinary 6-sulfatoxymelatonin level was associated with more hours of daylight, older age, higher body mass index, current alcohol consumption, and current use of medications classified as beta blockers, calcium channel blockers, or psychotropics. After adjustment for these factors, higher bedroom magnetic field level was associated with significantly lower urinary concentration of 6-sulfatoxymelatonin during the same night, primarily in women who used these medications and during times of the year with the fewest hours of darkness. These results suggest that exposure to nighttime residential 60-Hz magnetic fields can depress the normal nocturnal rise in melatonin.</abstract><cop>Cary, NC</cop><pub>Oxford University Press</pub><pmid>11581092</pmid><doi>10.1093/aje/154.7.591</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9262 |
ispartof | American journal of epidemiology, 2001-10, Vol.154 (7), p.591-600 |
issn | 0002-9262 1476-6256 0002-9262 |
language | eng |
recordid | cdi_proquest_miscellaneous_71209341 |
source | Oxford Journals Online |
subjects | Adrenergic beta-Antagonists - pharmacology Adult Age Factors Aged Alcohol Drinking Biological and medical sciences BMI Body Mass Index breast neoplasms Breast Neoplasms - etiology Calcium Channel Blockers - pharmacology carcinogens Circadian Rhythm electricity electromagnetic fields environmental Female Gynecology. Andrology. Obstetrics Humans Lighting Magnetics Mammary gland diseases Medical sciences melatonin Melatonin - analogs & derivatives Melatonin - urine Menopause Middle Aged Psychotropic Drugs - pharmacology Residence Characteristics Risk Factors Seasons Smoking Tumors |
title | Residential Magnetic Fields, Light-at-Night, and Nocturnal Urinary 6-Sulfatoxymelatonin Concentration in Women |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T01%3A57%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Residential%20Magnetic%20Fields,%20Light-at-Night,%20and%20Nocturnal%20Urinary%206-Sulfatoxymelatonin%20Concentration%20in%20Women&rft.jtitle=American%20journal%20of%20epidemiology&rft.au=Davis,%20Scott&rft.date=2001-10-01&rft.volume=154&rft.issue=7&rft.spage=591&rft.epage=600&rft.pages=591-600&rft.issn=0002-9262&rft.eissn=1476-6256&rft.coden=AJEPAS&rft_id=info:doi/10.1093/aje/154.7.591&rft_dat=%3Cproquest_cross%3E71209341%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c450t-a3a1a519613527040d329a793e88f2c0f9b9a38de8c6bc4566ba80ed891c6a483%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=235868457&rft_id=info:pmid/11581092&rfr_iscdi=true |